Ads
related to: von willebrand disease perioperative treatment- Patient Support Page
Find information about a support
program for your patients.
- On-Demand Information
This treatment is indicated for use
as an on-demand therapy for VWD.
- Dosing Guidelines
Find dosing guidelines
for 3 indications.
- Surgery Information
See how this treatment is used to
prepare for surgeries.
- Patient Support Page
Search results
Results from the WOW.Com Content Network
Vonicog alfa, sold under the brand names Vonvendi and Veyvondi, is a medication used to control bleeding in adults with von Willebrand disease (an inherited bleeding disorder). [6] [5] [7] [8] It is a recombinant von Willebrand factor. [6] [5] The most common adverse reactions are generalized itching, vomiting, nausea, dizziness, and vertigo. [6]
Von Willebrand disease (VWD) is the most common hereditary blood-clotting disorder in humans. An acquired form can sometimes result from other medical conditions. [ 1 ] It arises from a deficiency in the quality or quantity of von Willebrand factor (VWF), a multimeric protein that is required for platelet adhesion .
It is also used for perioperative management and routine prophylaxis to prevent or reduce the frequency of bleeding episodes. Turoctocog alfa is not indicated for the treatment of von Willebrand disease. [16] [9]
Type 1 von Willebrand Disease in dogs. Type 1 von Willebrand Disease is the most common type, and also the mildest. It occurs when dogs have a mild deficiency in all the proteins making up their ...
Chronic kidney failure, liver disease, haematological malignancy, recent or current chemotherapy, advanced heart failure, mild forms of inherited bleeding disorders (e.g. haemophilia, Von Willebrand's disease) and idiopathic thrombocytopenic purpura.
Coagulopathy (also called a bleeding disorder) is a condition in which the blood's ability to coagulate (form clots) is impaired. [1] This condition can cause a tendency toward prolonged or excessive bleeding (bleeding diathesis), which may occur spontaneously or following an injury or medical and dental procedures.
Desmopressin (DDAVP) is usually the first line treatment for mild to moderate type 1 von Willebrand disease. [1] It is not recommended in severe disease or in those with abnormal factor VIII. [1] Usefulness in type 2A, 2M, or 2N von Willebrand disease is variable. [1] Generally not recommended in 2B and type 3 von Willebrand disease. [1]
Ristocetin forms complexes with von Willebrand factor (vWF) that bind to the glycoprotein Ib (GP1b) receptors on platelets, causing platelet activation and aggregation. Reduced or absent aggregation in response to ristocetin can be caused by a lack of or reduction of vWF, as seen in von Willebrand disease (vWD), or absence or reduction in ...
Ads
related to: von willebrand disease perioperative treatment